Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to determine whether nebulized RNS60 is effective in the treatment of amyotrophic lateral sclerosis (ALS).
Epistemonikos ID: d7c3f7b4f227e85a539424c140fbde19190a95f0
First added on: May 20, 2024